Making The Most Of A Renaissance Moment In Health Care
The Many Good Things To Emerge From The Havoc Wrought By COVID Must Not Be Squandered
Executive Summary
The rise of digital alongside long-established physical methods of care delivery should not give rise to notions of an "either/or" choice, but should rather be seen as an “and,” said Accenture’s Andrew Meade in conversation with In Vivo.
You may also be interested in...
How COVID Boosted Medtech In The Eyes Of The World
Reaching deep and being resourceful were the in-demand attributes that medtech industry leaders brought to bear when the COVID-19 pandemic stretched health care providers almost to breaking point.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.